Group One Trading, L.P. Gemini Therapeutics, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$1.31 - $2.01 $8,456 - $12,974	6,455 New	6,455 $11,000
Q1 2022 May 12, 2022	SELL	$1.29 - $3.08 $428 - $1,022	-332 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$2.39 - $4.0 $4,677 - $7,828	-1,957 Reduced 85.5%	332 $1,000
Q3 2021 Nov 12, 2021	SELL	$3.3 - $6.32 $22,657 - $43,393	-6,866 Reduced 75.0%	2,289 $9,000
Q2 2021 Aug 10, 2021	SELL	$6.32 - $14.02 $68,534 - $152,032	-10,844 Reduced 54.22%	9,155 $59,000
Q1 2021 May 12, 2021	BUY	$11.32 - $18.0 $226,388 - $359,982	19,999 New	19,999 $271,000

2.44M

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.